Drug Profile
Naltrexone oral
Alternative Names: Low-dose naltrexone (LDN) - Transparency Life Sciences; Nalorex; Nemexin; ReviaLatest Information Update: 28 Oct 2021
Price :
$50
*
At a glance
- Originator DrugAbuse Sciences
- Developer Transparency Life Sciences
- Class Anti-inflammatories; Antineoplastics; Antivirals; Cyclopropanes; Drug withdrawal therapies; Ethers; Eye disorder therapies; Irritable bowel syndrome therapies; Ketones; Morphinans; Non-opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Alcoholism; Opioid-related disorders
- No development reported Crohn's disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Crohn's-disease in USA (PO)
- 18 Dec 2012 Early research in Crohn's disease in USA (PO)
- 01 Feb 2012 Early research in Inflammatory bowel disease in USA (PO)